The schizophrenia market was valued at USD 7.78 billion in 2024 and is projected to grow at a CAGR of 5.80%, reaching USD 13.67 billion by 2034. Growth is driven by increasing mental health awareness, improved diagnostic rates, and advancements in antipsychotic drug therapies across global healthcare systems. https://www.expertmarketresearch.com/reports/schizophrenia-market